1667 Objectives: To explore the role of 18 F-fluorodeoxyglucose (FDG) PET/CT in early
detection of therapy-associated cardiotoxicity (TACT) in lymphoma patients and to analyze …

Background: It is uncertain whether myocardial fluorodeoxyglucose uptake occurs solely
due to physiological features or if it represents a metabolic disarrangement under …

1574 Purpose: To evaluate the ability of (18) F-fluorodeoxyglucose (FDG) imaging for the
detection of cardiac lymphoma (CL) which contains heart involvement and pericardium …

The objective of this case report was to present the progression of chemotherapy-induced
cardiotoxicity in a patient with lymphoma, highlighting the importance of myocardial fluor-18 …

488 Background: Cardiac lymphoma is very rare. The most common location is the right
atrium, which needs to be differentiated from metastasis and primary cardiac angiosarcoma …

Arquivos Brasileiros de Cardiologia should be carefully considered by cardiologists
engaged in Precision Medicine. In this study, 1 the authors investigated the intensity of 2 …

According to reports, metastasis of malignant tumors to the heart is a rare condition, and
malignant lymphoma accounts for about 9%. Autopsy results showed that approximately …

1549 Objectives The aim of this study was to determine whether the routine oncologic FDG
PET/CT could be used for evaluating cancer therapy-induced cardiotoxicity in breast cancer …

18 F-fluorodeoxyglucose (18 F-FDG) positron emission tomography (PET)/computed
tomography (CT) plays an important role in the staging, detection of recurrence and …

Cardiac metastasis occurs in up to a quarter of patients with metastatic cancer and is seen
most commonly in melanoma and lymphoma. Metastatic involvement of the heart and …